-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cullinan Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2024.
- Cullinan Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$38.2M, a 25% increase year-over-year.
- Cullinan Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$145M, a 8.21% decline from 2023.
- Cullinan Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$134M, a 6.01% decline from 2022.
- Cullinan Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$127M, a 192% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)